| Literature DB >> 28303115 |
Guodong Song1, Chunmei Li2, Xiaojie Luo2, Xuna Zhao3, Shuai Zhang1, Yi Zhang3, Shanshan Jiang3, Xianlong Wang4, Yuhui Chen5, Haibo Chen5, Tao Gong5, Jinyuan Zhou3, Min Chen1.
Abstract
Amide proton transfer-weighted (APTW) magnetic resonance imaging (MRI) has recently become a potentially important tool for evaluating acidosis in ischemic stroke. The purpose of this study was to evaluate the dynamic pH-related changes in the lesions in patients with ischemia. Thirty-nine patients with ischemic stroke (symptom onset to imaging time ranging 2 h-7 days) were examined with a 3.0-T MRI system. Patients were divided into four groups: at the hyperacute stage (onset time ≤ 6 h), at the acute stage (6 h < onset time ≤ 48 h), at the early subacute stage (48 h < onset time ≤ 96 h), and at the late subacute stage (96 h < onset time ≤ 168 h). The APTW signal intensities were quantitatively measured in multiple ischemic regions for each patient. Compared with the contralateral normal white matter, APTW signals were significantly lower in ischemic tissue for all four stages (P < 0.05). The APTW signal intensities (APTWave and APTWmin) increased consistently with onset time (R2 = 0.11, P = 0.040; R2 = 0.13, P = 0.022, respectively). APTWmax-min showed a continued reduction with onset time (R2 = 0.44, P < 0.001). Our results suggest that persistent tissue acidification could occur after ischemia, and as the time from stroke onset increases, the acidotic environment would alleviate. APTW signal intensities could reflect pH-weighted properties in ischemic tissue at different stages and time points.Entities:
Keywords: APT imaging; chemical exchange saturation transfer imaging; magnetization transfer; pH; stroke
Year: 2017 PMID: 28303115 PMCID: PMC5332413 DOI: 10.3389/fneur.2017.00067
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Figure 1Examples of the definition of the regions of interest (ROIs). Five ROIs in the ischemic tissue and one ROI in the contralateral normal white matter were chosen.
Baseline demographic data for patients with different stages.
| Variable | Hyperacute stage (0–6 h) | Acute stage (6–48 h) | Early subacute stage (48–96 h) | Late subacute stage (96–168 h) | |
|---|---|---|---|---|---|
| Age (years) | 63 ± 6 | 66 ± 4 | 58 ± 4 | 61 ± 2 | 0.587 |
| Male/female | 2/2 | 10/8 | 6/4 | 5/2 | 0.769 |
| Onset time (h) | 4.5 ± 1.0 | 31.5 ± 2.9 | 79.2 ± 3.7 | 147.4 ± 6.3 | <0.001 |
.
Figure 2Measured MTR. (A) Hyperacute stage. (B) Acute stage. (C) Early subacute stage. (D) Late subacute stage. (E) The combination of MTRasym spectra in the ischemic tissue of different stages. (F) The combination of MTRasym spectra in the CNWM of different stages. The chemical exchange saturation transfer effect reduced in the offset range of 2–5 ppm in all stages. MTRasym(3.5 ppm) showed the largest reduction in the hyperacute stage (A). An increase was shown in the MTRasym(3.5 ppm) in the ischemic tissue (E).
Figure 3APT and conventional MR images for different stage patients. (A) F/50 years, a hyperacute stage patient at 2 h after symptom onset. APTWave = −0.83%, APTWmax–min = 1.30%. (B) M/54 years, an acute stage patient at 17 h after symptom onset. APTWave = −0.63%, APTWmax–min = 0.99%. (C) F/62 years, an early subacute stage patient at 72 h after symptom onset. APTWave = −0.40%, APTWmax–min = 0.72%. (D) M/54 years, a late subacute stage patient at 120 h after symptom onset. APTWave = 0.03%, APTWmax–min = 0.53%. Note the presence of CSF artifacts (black thin arrows).
Amide proton transfer-weighted (APTW) intensity values among four stages (%; mean value ± SE).
| Variable | Hyperacute stage | Acute stage | Early subacute stage | Late subacute stage |
|---|---|---|---|---|
| APTWave | −0.85 ± 0.02 | −0.64 ± 0.09 | −0.48 ± 0.11 | −0.34 ± 0.10 |
| APTWmax | −0.02 ± 0.04 | −0.24 ± 0.07 | −0.23 ± 0.10 | −0.11 ± 0.07 |
| APTWmin | −1.24 ± 0.04 | −1.06 ± 0.10 | −0.85 ± 0.08 | −0.70 ± 0.09 |
| APTWmax–min | 1.22 ± 0.06 | 0.82 ± 0.07 | 0.62 ± 0.05 | 0.59 ± 0.07 |
| APTW@CNWM | 0.15 ± 0.01 | 0.14 ± 0.01 | 0.14 ± 0.02 | 0.16 ± 0.01 |
.
MTR(15.6 ppm) intensity values in the ischemic lesion and the contralateral normal white matter (CNWM) among four stages (%; mean value ± SE).
| Variable | Hyperacute stage | Acute stage | Early subacute stage | Late subacute stage | Analysis of variance |
|---|---|---|---|---|---|
| Lesion | 26.61 ± 0.89 | 26.30 ± 0.99 | 25.39 ± 1.08 | 23.63 ± 2.58 | 0.625 |
| CNWM | 31.14 ± 1.15 | 31.08 ± 0.77 | 30.91 ± 1.92 | 29.36 ± 1.89 | 0.840 |
.
Figure 4Experimental and fitted time-related changes of different amide proton transfer-weighted (APTW) values in the ischemic tissue. (A) APTWave values (R2 = 0.11, P = 0.040); (B) APTWmin values (R2 = 0.13, P = 0.022); (C) APTWmax–min values (R2 = 0.44, P < 0.001).